BC scientists uncover new subtypes of ovarian cancer with new potential treatment strategies

Vancouver, B.C. – BC Cancer Agency scientists have uncovered seven new subtypes of ovarian cancer, which could result in new treatment strategies for some ovarian cancer patients including those that do not respond well to chemotherapy. The discovery, published in Nature Genetics , analyzed the genetic information of more than 100 ovarian cancer patients in order to identify abnormalities in the...

Two BC Cancer Agency drug discoveries identified as novel treatment options for patients with breast cancer

VANCOUVER, B.C. – Two exciting drug discoveries have been made at the BC Cancer Agency by Dr. Sam Aparicio, head of the Department of Breast and Molecular Oncology, and his team. Both discoveries are opening up new approaches to targeting cancers more specifically, by exploiting mutations present in cancer cells that are not present in normal cells. The first discovery, which has already led to a...

BC Cancer Agency researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions

VANCOUVER, B.C. – BC Cancer Agency researcher – Dr. Sam Aparicio – has been announced as a member of one of the first global research teams to be recipients of Cancer Research UK’s Grand Challenge. The Grand Challenge aims to help overcome the biggest challenges facing cancer research in a global effort to beat cancer sooner. The winning projects are set to revolutionize our understanding of...

BC Cancer Agency researchers recognized for groundbreaking projects

$1.5 M awarded to seven researchers to advance cancer detection and care
VANCOUVER, B.C. – Today on World Cancer Day, the BC Cancer Foundation and BC Cancer Agency announce the recipients of $1.5 M in funding to advance cancer detection and care through a brand new program titled the Strategic Priority Fund Awards. The funding will provide seven BC Cancer Agency research recipients with innovative cancer projects the opportunity to advance groundbreaking research that...

New genetic tests become standard of cancer care in BC

Vancouver – New multi-gene analysis panels are now available to oncologists and haematologists across British Columbia as provincial diagnostic tools, meaning a more personalized approach to treatment for thousands of eligible cancer patients. The OncoPanel and Myeloid Panel are clinical tests that can detect multiple different mutations in several genes simultaneously associated with solid or...

Why Biology Matters When it comes to Conquering Breast Cancer

Building on the world’s largest breast cancer study, BC Cancer Agency scientists map the relationship between cancer mutations and clinical outcomes in 2,433 women. Dr. Samuel Aparicio co-led a study with Dr. Carlos Caldas from Cancer Research UK and these teams have shown that what lies beneath the surface is critical as no two breast cancers are alike when you dig deeper. Building on a landmark...

Scientists map the spread of deadliest ovarian cancer

Vancouver – BC Cancer Agency researchers are providing critical insight into the invasive spread of the most malignant form of ovarian cancer in a landmark study, published today in Nature Genetics . This is a first in mapping two distinct patterns of ovarian cancer cell migration in high grade serous ovarian cancer. Dr. Sohrab Shah The discovery, led by Dr. Sohrab Shah, senior scientist at the...

Researchers Find Cause of Rare Gastric Cancer

VANCOUVER, B.C. – Today, families around the world have answers as to what’s causing a long history of stomach cancer. The international study involved BC Cancer Agency researchers and has discovered the genetic cause of a rare gastric condition that can lead to stomach cancer. The team, including Dr. David Huntsman, Distinguished Scientist at the BC Cancer Agency and Professor in the Departments...

A made-in-B.C. prostate cancer drug entering clinical trials

VANCOUVER, BC – A prostate cancer drug developed by researchers at the BC Cancer Agency and the University of British Columbia is entering human clinical trials. The drug is specifically designed to target and shut down metastatic castrate resistant prostate cancer (m-CRPC) when other treatments have failed. "Today represents a significant milestone as we witness the fruits of our labour in the...

BC Cancer Agency Researchers Develop Prognostic Test for Follicular Lymphoma

Vancouver – BC Cancer Agency researchers have published important findings with the power to predict patient response to existing treatment regimens. The results were released in The Lancet Oncology . The study, carried out in collaboration with scientists at the University Hospital of the Ludwig-Maximilians, University Munich, and collaborators at the Dana Farber Cancer Institute in Boston...

Pages